Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Marburg Hemorrhagic Fever”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Early research (Phase 1)Study completedNCT02891980
What this trial is testing

A Safety Trial to Test MVA-BN(R)-Filo and Ad26.ZEBOV Vaccines in Healthy Volunteers

Who this might be right for
Ebola DiseaseMarburg Disease
National Institute of Allergy and Infectious Diseases (NIAID) 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT06620003
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults

Who this might be right for
Marburg Virus Disease
Albert B. Sabin Vaccine Institute 200
Early research (Phase 1)Study completedNCT00997607
What this trial is testing

Evaluating an Ebola and a Marburg Vaccine in Uganda

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 108
Early research (Phase 1)Study completedNCT03475056
What this trial is testing

CAd3-Marburg Vaccine in Healthy Adults

Who this might be right for
Marburg Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT01353040
What this trial is testing

Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus

Who this might be right for
Marburg Hemorrhagic Fever
Sarepta Therapeutics, Inc. 30
Early research (Phase 1)Study completedNCT03800173
What this trial is testing

Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430

Who this might be right for
Marburg Virus Disease
BioCryst Pharmaceuticals 32
Early research (Phase 1)Looking for participantsNCT07425821
What this trial is testing

Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health

Who this might be right for
Marburg Virus Disease
International AIDS Vaccine Initiative 112
Early research (Phase 1)Study completedNCT04723602
What this trial is testing

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
Albert B. Sabin Vaccine Institute 32
Early research (Phase 1)Study completedNCT00605514
What this trial is testing

Ebola and Marburg Virus Vaccines

Who this might be right for
Ebola VaccinesMarburg Virus DiseaseEbola Virus Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT01566877
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers

Who this might be right for
Marburg Hemorrhagic Fever
Sarepta Therapeutics, Inc. 40
Early research (Phase 1)Study completedNCT06265012
What this trial is testing

Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects

Who this might be right for
Marburg Virus Disease
Public Health Vaccines LLC 36
Testing effectiveness (Phase 2)Study completedNCT05817422
What this trial is testing

Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults

Who this might be right for
Marburg Virus Disease
Albert B. Sabin Vaccine Institute 126